Ramtin Agah
Physician in Menlo Park, CA

License number
Utah 5122566-8905
Issued Date
Jul 1, 2002
Expiration Date
Jan 31, 2006
Category
Physician
Type
Physician/Surgeon CS (Schedule 2-5)
Address
Address
Menlo Park, CA
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL

Professional information

Ramtin Agah Photo 1

Devices, Methods And Kits For Delivery Of Therapeutic Materials To A Pancreas

US Patent:
2011029, Dec 1, 2011
Filed:
Dec 2, 2010
Appl. No.:
12/958711
Inventors:
Ramtin Agah - Menlo Park CA, US
Kamran Najmabadi - Palo Alto CA, US
Assignee:
RENOVORX - Palo Alto CA
International Classification:
A61M 25/10, A61B 6/00
US Classification:
600435, 60410105, 604509
Abstract:
Devices and methods are described herein for engraftment of stem cells into a pancreas using an endovascular approach. Targeted intra-arterial injection of stem cells selectively in a splenic artery can achieve engraftment of insulin producing cells in the tail of the pancreas with high efficiency and without systemic circulation of these cells to other organs. In one embodiment, a catheter device includes expandable occlusion elements in the form of inflatable balloons that can be used to isolate a proximal and distal end of a pancreatic portion of the splenic artery. In another embodiment, the occlusion elements include a filter element instead of a balloon. In some embodiments, targeted delivery of stem cells to the pancreatic tail can be achieved for treatment of, for example, diabetes. In some embodiments, an arterial section of the splenic artery can be isolated for selective perfusion of therapeutic cells/drugs to the tail of the pancreas.


Ramtin Agah Photo 2

Methods And Probes For Identifying Vulnerable Plaque

US Patent:
2007016, Jul 19, 2007
Filed:
Apr 5, 2004
Appl. No.:
10/551513
Inventors:
Ramtin Agah - Menlo Park CA, US
International Classification:
A61K 49/00, C12Q 1/68, C07H 21/04
US Classification:
424009600, 435006000, 536023100
Abstract:
The present application discloses methods for detecting and localizing injuries in the vascular system of a subject, and in particular provides methods for detecting vulnerable or unstable plaques using oligo-deoxynucleotides (ODNs).